pre-announce better fear
market open issu press releas pre-announc
result provid updat outbreak also
withdraw guidanc due uncertainti regard impact covid-
pandem join number compani pull guid
expect report revenu growth core revenu growth vs
guid benefit extra sell day saw growth
segment particular strength cepheid radiomet dhr point-of-car
diagnost unit pall suggest demand bioprocess remain steadi
chemtreat note instrument demand began wane toward end
march pandem spread world-wide provid full financi result may
durat crisi key
key uncertainti regard durat social distanc measur
note recent sector note assum academ government lab account
estimate total sale experi disrupt pharma
lab benefit exposur bioprocess drug
manufactur expect headwind industri end market increas
tailwind test may enough off-set
expect hit reduc routin test volum clinic hospit dx
assum impact china account total sale
occur eu us custom combin nearli
sale larger headwind slow recov start late
estimate core revenu growth vs prior declin
ep est vs prior
dhr dental busi gone ge deal close believ compani portfolio
well-posit weather storm reiter buy rate
full definit iqmethod sm measur see page
bofa secur seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
net dbt
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
one largest diversifi
product includ analyt instrument
consum life scienc research
diagnost dental instrument consum
equip servic use water qualiti
test product identif compani
known lead brand across mani
vertic strong manag team
record superior execut
follow spin-off industrial-them
becam one premier stand-
acquisit ge life scienc busi
divestitur dental segment
transform compani
profil free cash flow gener potenti
po base dcf analysi assum wacc termin growth rate
believ pend deal transform
downsid risk po fx risk econom risk cyclic exposur reduct
 fund custom consolid slowdown bioprocess demand competit
risk risk pend acquisit complet
derik de bruin herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
us life scienc diagnost tool anim health coverag cluster
qualiti earn
iqmethod smi set bofa global research standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa global research
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
